Lista de obras -

A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics

artículo científico publicado en 2005

An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial

artículo científico publicado en 2010

Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials

artículo científico publicado en 2017

Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure).

artículo científico publicado en 2010

Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction

artículo científico publicado en 2014

Declining Risk of Sudden Death in Heart Failure

artículo científico publicado en 2017

Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF.

artículo científico publicado en 2015

Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure).

artículo científico publicado en 2014

Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis

artículo científico publicado en 2009

Fatigue as a Predictor of Outcome in Patients With Heart Failure

article

Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) ⬇️

artículo científico publicado el 17 de abril de 2012

Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure

scientific article published on 01 December 2019

Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA.

artículo científico publicado en 2013

Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA).

artículo científico publicado en 2010

International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction

artículo científico publicado en 2014

Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure

artículo científico publicado en 2017

Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.

artículo científico publicado en 2015

Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA).

artículo científico publicado en 2016

Novel extracellular matrix biomarkers as predictors of adverse outcome in chronic heart failure: association between biglycan and response to statin therapy in the CORONA trial

artículo científico publicado en 2014

Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.

artículo científico

Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials

artículo científico publicado en 2012

Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in

artículo científico publicado en 2009

Predictive value of endostatin in chronic heart failure patients with poor kidney function

artículo científico publicado en 2014

Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide

artículo científico publicado en 2009

Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial

artículo científico publicado en 2013

Prognostic value of CXCL16 in patients with left ventricular systolic dysfunction and heart failure

artículo científico publicado en 2013

Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

artículo científico publicado en 2014

Response to Letter Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della So

artículo científico publicado en 2015

Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca

artículo científico publicado en 2015

Rosuvastatin in older patients with systolic heart failure

artículo científico publicado en 2007

Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology

artículo científico publicado en 2012

Telomere length and outcomes in ischaemic heart failure: data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA).

artículo científico publicado en 2015

The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

artículo científico publicado en 2012

Thyroid-stimulating hormone and clinical outcomes: the CORONA trial (controlled rosuvastatin multinational study in heart failure).

artículo científico publicado en 2014

Lista de obras de

A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics

An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial

Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials

Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure).

Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction

Declining Risk of Sudden Death in Heart Failure

Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF.

Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure).

Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis

Fatigue as a Predictor of Outcome in Patients With Heart Failure

Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) ⬇️

Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure

Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA.

Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA).

International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction

Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure

Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.

Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA).

Novel extracellular matrix biomarkers as predictors of adverse outcome in chronic heart failure: association between biglycan and response to statin therapy in the CORONA trial

Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.

Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials

Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in

Predictive value of endostatin in chronic heart failure patients with poor kidney function

Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide

Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial

Prognostic value of CXCL16 in patients with left ventricular systolic dysfunction and heart failure

Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

Response to Letter Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della So

Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca

Rosuvastatin in older patients with systolic heart failure

Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology

Telomere length and outcomes in ischaemic heart failure: data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA).

The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

Thyroid-stimulating hormone and clinical outcomes: the CORONA trial (controlled rosuvastatin multinational study in heart failure).